Poly Medicure’s board approved the unaudited financial results for Q2, ending September 30, 2025. Standalone revenue reached ₹41,654.17 lacs. The group finalized the acquisition of Pendra Care Group. The QIP proceeds of ₹99,999.98 lacs, raised in August 2024, are being utilized for capital expenditure, inorganic initiatives, and repayment of working capital.
Q2 Financial Performance
Poly Medicure announced its unaudited standalone financial results for the second quarter of fiscal year 2025, concluding on September 30, 2025. Key figures include:
- Revenue from operations: ₹41,654.17 lacs
- Total Income: ₹45,026.27 lacs
- Profit after tax: ₹8,905.05 lacs
- Earnings per share (Basic): ₹8.79
Consolidated Results Highlights
The consolidated results present a broader financial picture, incorporating the performance of subsidiaries and associates:
- Total Income: ₹47,782.59 lacs
- Profit after tax: ₹9,179.75 lacs
Pendra Care Group Acquisition Completed
The group has officially acquired 90% economic rights in Pendra Care Group, enhancing its market presence and product portfolio. The acquisition cost settled in cash amounted to ₹15,059.34 lacs. This strategic move is expected to yield synergetic benefits. Assets and liabilities of the acquired group are consolidated in the financial statements on a provisional basis, pending final fair value assessment within a year.
Utilization of QIP Proceeds
The ₹99,999.98 lacs raised through the Qualified Institutional Placement (QIP) in August 2024 has been allocated as follows:
- Capital expenditure: ₹2,922.78 lacs
- Inorganic Initiatives: ₹15,093.34 lacs
- Repayment of working capital: ₹10,740.11 lacs
Himalayan Mineral Water Update
The resolution plan for Himalayan Mineral Water Private Limited, approved by NCLT Allahabad, is awaiting final formalities. The company has deposited ₹3,316.00 lacs with the resolution professional. Transfer of ownership is pending.
Source: BSE
